|
Status |
Public on Dec 31, 2017 |
Title |
Duke/RG_Runx1Runx2_v1 (Agilent 4x180k) |
Technology type |
in situ oligonucleotide |
Distribution |
custom-commercial |
Organism |
Homo sapiens |
Manufacturer |
Agilent Technologies |
Manufacture protocol |
In situ oligosynthesized array with proprietary synthetic sequences that target Runx1/Runx2 putative binding sites in genomic context.
|
|
|
|
|
Submission date |
Apr 12, 2017 |
Last update date |
Dec 31, 2017 |
Contact name |
Raluca Gordan |
E-mail(s) |
raluca.gordan@duke.edu
|
Organization name |
Duke University
|
Department |
Center for Genomic and Computational Biology
|
Street address |
101 Science Dr, CIEMAS 2179
|
City |
Durham |
State/province |
NC |
ZIP/Postal code |
27708 |
Country |
USA |
|
|
Samples (4) |
GSM2575567, GSM2575568, GSM2575569, GSM2575570 |
Series (2) |
GSE97691 |
Divergence in DNA specificity among paralogous transcription factors contributes to their differential in vivo binding [RG_Runx1Runx2_v1] |
GSE97794 |
Divergence in DNA specificity among paralogous transcription factors contributes to their differential in vivo binding |
|